Infectious Disease Clinical Development Expertise

Getting a novel infectious disease vaccine or treatment on the market today is extremely critical and complex. 

Infectious diseases are a threat to global health and way of life everywhere – particularly in the midst of the current COVID-19 pandemic. Time is of the essence when it comes to developing safe and effective infectious disease vaccines and treatments.  In addition to recent pandemic outbreaks caused by viral infections, more treatment-resistant bacterial and fungal infections are rising, with antibiotics and antifungals becoming less effective.

Our scientific-minded infectious disease experts can help navigate this challenging landscape, having conducted more than 250 programs for Infectious Disease treatments and vaccines.

Experience Battling Infectious Diseases

Whether you are aiming to prevent or combat a viral, bacterial, fungal or parasitic infection, Veristat can help make the difference for your study’s success. Our teams understand the nuances and difficulties involved with treating infectious diseases, have the experience to perform vaccine trials, and are adept with rapid response to global pandemics that arise, such as the current COVID-19 outbreak response.   

At Veristat, our experienced teams are poised to plan and implement these efforts quickly providing:    

Recent Pandemic Experience
Veristat_icon_infectious disease-216

> 250

Clinical trials for infectious disease treatments and vaccines


> 20 COVID-19


> 50 Influenza

vaccine programs

8 Ebola

vaccine projects for 2014 outbreak

Explore Our Recent Infectious Disease Experience

Prevention and Treatment of Bacterial & Fungal Infections
Acinetobacter Baumannii Infections
Gram-Negative Infections
Acute Bacterial Skin and Skin Structure Infections (ABSSI) 
H. Pylori Infection
Bacterial Pneumonia 
Joint infection 
Botulinum vaccine
Methicillin-resistant Staphylococcus aureus (MRSA) Bacteremia 
Nasal Infection 
Clostridium Difficile (C.Diff) 
Nontuberculous Mycobacterial (NTM) Lung Disease
Complicated Intra-Abdominal Infections (cIAI) 
Nosocomial Infection


Prevention and Treatment of Viruses/Viral Infection​
COVID 19 ​
Influenza- Pandemic ​
Cytomegalovirus (CMV) Infection ​
Lassa Fever
Epstein Barr Virus (EBV) ​
Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
Hepatitis A, B, and C ​
Recurrent Respiratory Papillomatosis (RRP)
Herpes (HSV2) ​
Respiratory Syncytial Virus ​
RNA Vaccine Platforms for multiple types of Infectious Diseases/Cancers ​
Human Papilloma Virus (HPV) ​
Shingles - Varicella-Zoster Virus (VZV)
Influenza - H1N1
Influenza - H5N1
Sexually Transmitted Infections
Influenza - Seasonal
Typhoid Fever
Influenza (Universal Vaccine)
West Nile Virus ​



Learn More with These Resources

Case Study
Rapid Launch of a Phase I COVID-19 Vaccine Trial

Learn how the Veristat team quickly mobilized to help a sponsor get their clinical trial databased designed and launched in two weeks in order to achieve ...

Case Study
Data Collection Efficiency for a Novel Anti-Infective ...

Learn how we improved data collection efficiency through thoughtful database design that allowed the sponsor to overcome a complex trial challenge and transition ...

Fact Sheet
COVID-19 Success Guide

As you consider the impact that the COVID-19 pandemic has on your programs, there are some key strategies that could help you maintain momentum, assess your risks and ...

Request A Proposal